These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34044804)

  • 21. Newcastle disease virus strain AF2240 as an oncolytic virus: A review.
    Kalyanasundram J; Hamid A; Yusoff K; Chia SL
    Acta Trop; 2018 Jul; 183():126-133. PubMed ID: 29626432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo.
    Xu Q; Rangaswamy US; Wang W; Robbins SH; Harper J; Jin H; Cheng X
    Int J Cancer; 2020 Jan; 146(2):531-541. PubMed ID: 31584185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model.
    Yurchenko KS; Glushchenko AV; Gulyaeva MA; Bi Y; Chen J; Shi W; Adamenko LS; Shestopalov AM
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.
    Jiang K; Li Y; Zhu Q; Xu J; Wang Y; Deng W; Liu Q; Zhang G; Meng S
    BMC Cancer; 2014 Jul; 14():551. PubMed ID: 25078870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy inhibition suppresses Newcastle disease virus-induced cell death by inhibiting viral replication in human breast cancer cells.
    Rozilah MI; Yusoff K; Chia SL; Ismail S
    Virology; 2024 Feb; 590():109957. PubMed ID: 38100982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity.
    Schwaiger T; Knittler MR; Grund C; Roemer-Oberdoerfer A; Kapp JF; Lerch MM; Mettenleiter TC; Mayerle J; Blohm U
    Int J Cancer; 2017 Dec; 141(12):2505-2516. PubMed ID: 28857157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines.
    Santos MR; Xavier PLP; Pires PRL; Rochetti AL; Rosim DF; Scagion GP; de Campos Zuccari DAP; Munir M; Ferreira HL; Fukumasu H
    Vet Comp Oncol; 2021 Sep; 19(3):593-601. PubMed ID: 33871162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined therapy of oncolytic Newcastle disease virus and rhizomes extract of Rheum ribes enhances cancer virotherapy in vitro and in vivo.
    Al-Shammari AM; Jalill RDA; Hussein MF
    Mol Biol Rep; 2020 Mar; 47(3):1691-1702. PubMed ID: 31970625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation.
    Vijayakumar G; Zamarin D
    Methods Mol Biol; 2020; 2058():133-154. PubMed ID: 31486036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells.
    Wang X; Shao X; Gu L; Jiang K; Wang S; Chen J; Fang J; Guo X; Yuan M; Shi J; Ding C; Meng S; Xu Q
    J Cell Mol Med; 2020 Apr; 24(7):4286-4297. PubMed ID: 32100392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The V protein in oncolytic Newcastle disease virus promotes HepG2 hepatoma cell proliferation at the single-cell level.
    Chu Z; Yang S; Li Q; Shang J; Ren Z; Ren F
    BMC Cancer; 2023 Apr; 23(1):346. PubMed ID: 37069523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
    Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
    J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells
    Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral persistence in colorectal cancer cells infected by Newcastle disease virus.
    Chia SL; Yusoff K; Shafee N
    Virol J; 2014 May; 11():91. PubMed ID: 24886301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways.
    Mozaffari Nejad AS; Fotouhi F; Mehrbod P; Keshavarz M; Alikhani MY; Ghaemi A
    Microb Pathog; 2020 Oct; 147():104438. PubMed ID: 32777353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells.
    Meng G; Xia M; Wang D; Chen A; Wang Y; Wang H; Yu D; Wei J
    Oncotarget; 2014 Aug; 5(15):6365-74. PubMed ID: 25051374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
    Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
    Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro.
    Burke S; Shergold A; Elder MJ; Whitworth J; Cheng X; Jin H; Wilkinson RW; Harper J; Carroll DK
    Cancer Immunol Immunother; 2020 Jun; 69(6):1015-1027. PubMed ID: 32088771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exosomes Carry microRNAs into Neighboring Cells to Promote Diffusive Infection of Newcastle Disease Virus.
    Zhou C; Tan L; Sun Y; Qiu X; Liao Y; Song C; Liu W; Nair V; Ding C
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31174402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma.
    Vijayakumar G; Palese P; Goff PH
    EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.